Virtu Financial’s Direxion Daily S&P Biotech Bear 1X Shares LABS Stock Holding History

Virtu Financial’s Portfolio LABS Stock Details LABS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30,373	Closed	-$863K	–	2552
2017 Q2	$863K	Sell	30,373 -8,029	-21%	-$250K	0.12%	158
2017 Q1	$1.23M	Buy	+38,402	New	+$1.33M	0.13%	121
2016 Q4	–	Sell	-38,582	Closed	-$1.46M	–	629
2016 Q3	$1.46M	Sell	38,582 -1,536	-4%	-$61.6K	0.25%	89
2016 Q2	$1.89M	Buy	40,118 +33,681	+523%	+$1.6M	0.25%	84
2016 Q1	$330K	Sell	6,437 -40,838	-86%	-$2.19M	0.05%	278
2015 Q4	$1.9M	Buy	+47,275	New	+$1.96M	0.27%	81

Virtu Financial's LABS Position: Q3 2017 in Review

Virtu Financial sold out of Direxion Daily S&P Biotech Bear 1X Shares (LABS) in Q3 2017, closing a stake of 30,373 shares — an estimated $863K sold.

Virtu Financial first reported a position in LABS in Q4 2015 and held it in 6 quarters. The position peaked at $1.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold LABS as of Q3 2017.

Virtu Financial reported no remaining Direxion Daily S&P Biotech Bear 1X Shares position as of Q3 2017 after selling out during the quarter.
Virtu Financial sold 30,373 Direxion Daily S&P Biotech Bear 1X Shares shares in Q3 2017, an estimated $863K.
Virtu Financial first reported a position in Direxion Daily S&P Biotech Bear 1X Shares in Q4 2015 and held it in 6 quarters.
Virtu Financial's Direxion Daily S&P Biotech Bear 1X Shares position peaked at $1.9M in Q4 2015.
0 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 1X Shares as of Q3 2017.

Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.